托卢烯暴露和血小板计数的变化:一个叙事性回顾
Gabriel Machado Romão da Silva1, Eric Slawka1, Aline de Souza Espíndola Santos2
1Faculdade de Medicina, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
概括
托卢暴露可能会影响血小板计数,但由于相互矛盾的结果和对其他化学物质的同时暴露,研究是不确定的. 更多的研究将多烯分离出来.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 血液学 血液学 血液学
背景情况:
- 托卢是一种常见的溶剂,已知有毒作用,包括神经和血液学损伤.
- 血小板在血液静止和炎症中起着至关重要的作用,它们的数量可能会受到环境暴露的影响.
研究的目的:
- 审查和综合现有证据,对托洛暴露和人类血小板数量之间的关系.
- 找出有关多烯血液学影响的当前研究中的差距.
主要方法:
- 在三个电子数据库和一个数字图书馆中进行了系统的文献搜索.
- 一个特定的搜索策略确定了64篇文章,其中14篇被选中进行审查.
- 选择的研究共有15759名参与者,其中13297人接触过烯,主要是在环境环境中.
主要成果:
- 审查的研究提出了关于托卢暴露和血小板计数之间的关联的相互矛盾的发现 (积极,反向或没有关联).
- 暴露环境中与其他化学物质的交叉污染使得评估烯的特定效应变得更加复杂.
- 发现大量缺乏精心设计的研究,特别是那些隔离托卢暴露的研究.
结论:
- 目前关于托卢烯对血小板数的影响的证据是不一致和有限的.
- 需要进一步高质量的研究来澄清这种关系,重点关注与混杂物质隔离的烯暴露.
- 了解托卢的血液学影响需要更有针对性的研究.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...


